featured
De-Escalation to Ticagrelor Monotherapy vs 12-Month DAPT in Patients With and Without Acute Coronary Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials
Lancet 2024 Sep 07;404(10456)937-948, M Valgimigli, SJ Hong, F Gragnano, K Chalkou, A Franzone, BR da Costa, U Baber, BK Kim, Y Jang, SL Chen, GW Stone, JY Hahn, S Windecker, MC Gibson, YB Song, Z Ge, P Vranckx, S Mehta, HC Gwon, RD Lopes, GD Dangas, EP McFadden, DJ Angiolillo, S Leonardi, D Heg, P Calabrò, P Jüni, R Mehran, MK HongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.